FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217773060> ?p ?o ?g. }

• W3217773060 endingPage "443" @default.
• W3217773060 startingPage "431" @default.
• W3217773060 abstract "Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with motor neuron loss as a defining feature. Despite significant effort, therapeutic breakthroughs have been modest. MN-166 (ibudilast) has demonstrated neuroprotective action by various mechanisms: inhibition of proinflammatory cytokines and macrophage migration inhibitory factor, phosphodiesterase inhibition, and attenuation of glial cell activation in models of ALS. Early-phase studies suggest that MN-166 may improve survival outcomes and slow disease progression in patients with ALS. This article describes the rationale and design of COMBAT-ALS, an ongoing randomized, double-blind, placebo-controlled, multicenter Phase IIb/III study in ALS. This study is designed to evaluate the pharmacokinetics, safety and tolerability and assess the efficacy of MN-166 on function, muscle strength, quality of life and survival in ALS.Lay abstract Amyotrophic lateral sclerosis (ALS) is a neurological disease defined by the loss of the nerve cells going to the muscles. Despite significant effort, we still do not have good treatments for ALS. MN-166 (ibudilast) can protect nerve cells by calming inflammation in several ways in models of ALS. Early human studies suggest that MN-166 may extend life and slow disease progression in ALS patients. This article describes the rationale and design of COMBAT-ALS, an ongoing randomized, double-blind, placebo-controlled, multicenter Phase IIb/III study. This study will show the drug’s safety and tolerability and its effects on physical function, muscle strength, quality of life and survival in people living with ALS. Trial registration number: NCT04057898 (ClinicalTrial.gov)." @default.
• W3217773060 created "2021-12-06" @default.
• W3217773060 creator A5005609900 @default.
• W3217773060 creator A5019225883 @default.
• W3217773060 creator A5030730290 @default.
• W3217773060 creator A5031853409 @default.
• W3217773060 creator A5039162922 @default.
• W3217773060 creator A5046488842 @default.
• W3217773060 creator A5049803861 @default.
• W3217773060 creator A5052581382 @default.
• W3217773060 creator A5053264151 @default.
• W3217773060 creator A5059136025 @default.
• W3217773060 creator A5071868715 @default.
• W3217773060 creator A5072258675 @default.
• W3217773060 creator A5075797171 @default.
• W3217773060 creator A5080025756 @default.
• W3217773060 creator A5080653646 @default.
• W3217773060 creator A5084777911 @default.
• W3217773060 creator A5091211796 @default.
• W3217773060 date "2021-12-01" @default.
• W3217773060 modified "2023-10-13" @default.
• W3217773060 title "MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design" @default.
• W3217773060 cites W1928416749 @default.
• W3217773060 cites W1967811268 @default.
• W3217773060 cites W1978727434 @default.
• W3217773060 cites W1987128031 @default.
• W3217773060 cites W1987728948 @default.
• W3217773060 cites W2000366267 @default.
• W3217773060 cites W2008082211 @default.
• W3217773060 cites W2016173304 @default.
• W3217773060 cites W2032618470 @default.
• W3217773060 cites W2039915132 @default.
• W3217773060 cites W2051274614 @default.
• W3217773060 cites W2059033057 @default.
• W3217773060 cites W2060230550 @default.
• W3217773060 cites W2068368057 @default.
• W3217773060 cites W2075642592 @default.
• W3217773060 cites W2079790110 @default.
• W3217773060 cites W2083985665 @default.
• W3217773060 cites W2084586262 @default.
• W3217773060 cites W2093791199 @default.
• W3217773060 cites W2096967123 @default.
• W3217773060 cites W2117998240 @default.
• W3217773060 cites W2118634615 @default.
• W3217773060 cites W2123779560 @default.
• W3217773060 cites W2128167427 @default.
• W3217773060 cites W2155221045 @default.
• W3217773060 cites W2162962363 @default.
• W3217773060 cites W2330989831 @default.
• W3217773060 cites W2513018262 @default.
• W3217773060 cites W2605839598 @default.
• W3217773060 cites W2616124858 @default.
• W3217773060 cites W2739956201 @default.
• W3217773060 cites W2765564017 @default.
• W3217773060 cites W2782270767 @default.
• W3217773060 cites W2810654871 @default.
• W3217773060 cites W2888865579 @default.
• W3217773060 cites W2965191972 @default.
• W3217773060 cites W2981269454 @default.
• W3217773060 cites W3012688546 @default.
• W3217773060 cites W3038161547 @default.
• W3217773060 cites W3082122716 @default.
• W3217773060 cites W3093261605 @default.
• W3217773060 cites W3115244068 @default.
• W3217773060 cites W3156493310 @default.
• W3217773060 cites W4239910162 @default.
• W3217773060 doi "https://doi.org/10.2217/nmt-2021-0042" @default.
• W3217773060 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34816762" @default.
• W3217773060 hasPublicationYear "2021" @default.
• W3217773060 type Work @default.
• W3217773060 sameAs 3217773060 @default.
• W3217773060 citedByCount "12" @default.
• W3217773060 countsByYear W32177730602022 @default.
• W3217773060 countsByYear W32177730602023 @default.
• W3217773060 crossrefType "journal-article" @default.
• W3217773060 hasAuthorship W3217773060A5005609900 @default.
• W3217773060 hasAuthorship W3217773060A5019225883 @default.
• W3217773060 hasAuthorship W3217773060A5030730290 @default.
• W3217773060 hasAuthorship W3217773060A5031853409 @default.
• W3217773060 hasAuthorship W3217773060A5039162922 @default.
• W3217773060 hasAuthorship W3217773060A5046488842 @default.
• W3217773060 hasAuthorship W3217773060A5049803861 @default.
• W3217773060 hasAuthorship W3217773060A5052581382 @default.
• W3217773060 hasAuthorship W3217773060A5053264151 @default.
• W3217773060 hasAuthorship W3217773060A5059136025 @default.
• W3217773060 hasAuthorship W3217773060A5071868715 @default.
• W3217773060 hasAuthorship W3217773060A5072258675 @default.
• W3217773060 hasAuthorship W3217773060A5075797171 @default.
• W3217773060 hasAuthorship W3217773060A5080025756 @default.
• W3217773060 hasAuthorship W3217773060A5080653646 @default.
• W3217773060 hasAuthorship W3217773060A5084777911 @default.
• W3217773060 hasAuthorship W3217773060A5091211796 @default.
• W3217773060 hasBestOaLocation W32177730601 @default.
• W3217773060 hasConcept C126322002 @default.
• W3217773060 hasConcept C142724271 @default.
• W3217773060 hasConcept C143998085 @default.
• W3217773060 hasConcept C151730666 @default.
• W3217773060 hasConcept C159110408 @default.

• next